To determine whether the protective effects of IP6 are mediated via the effect on the expansion of the TICs/CSCs pool, we analyzed the TICs pool (for dual expression of CD44 and BMI-1) as a function of tumor aggressiveness (with or without IP6 treatment). This evidence concerns the gene BMI1 and neoplasm.